1Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea
2College of Korean Medicine, Woosuk University, Jeonju, Republic of Korea
3Department of Korean Medicine Rehabilitation, Bucheon Jaseng Hospital of Korean Medicine, Bucheon, Republic of Korea
4Department of Preventive Medicine, College of Korean Medicine, Woosuk University, Jeonju, Republic of Korea
©2025 Jaseng Medical Foundation
This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Conflicts of Interest
The authors have no conflicts of interest to declare
Funding
None
Ethical Statement
Not applicable
Author (y) [ref] | Treatment (n) | Age (y) | Pregnancy period (wk) | Group 1 | Group 2 | Group 3 | Results |
---|---|---|---|---|---|---|---|
Dong (2015) [18] |
EA1 (60) EA2 (60) Control (60) |
EA1 29.40 ± 2.96 EA2 29.12 ± 2.88 Control 28.98 ± 2.64 |
- | EA on EX-B2 | EA on SP6 | Control (routine intrapartum care) |
(EA1 vs control / EA2 vs control) 1. VAS Scores (positive b, positive b) 2. Active labor phase duration (positive b, positive a) 3. Neonatal outcomes (NS) |
Jin (2023) [15] |
EA1 (53 EA2 (53) Sham EA (52) |
EA1 30.83 ± 3.59 EA2 30.13 ± 3.31 Sham EA 31.19 ± 3.37 |
37.96 ± 1.64 38.32 ± 1.45 38.19 ± 1.28 |
PCIA (patient-controlled intravenous analgesia) + 2 Hz EA on ST36, SP6 | PCIA + 20/100 Hz EA on ST36, SP6 | PCIA + Sham EA |
(EA1 vs sham EA / EA2 vs sham EA) 1. NAPC (number of analgesic pump compressions) at 6, 12, 24, 48 h (positive c, positive c) 2. VAS Scores at 6, 12, 24, 48 h (positive c, positive c) 3. Fentanyl consumption at 6, 12, 24, 48h (positive c, positive b† ) 4. time to first exhaust (NS, NS) 5. Serum IL-6, PCT at 12, 48 h (NS between three groups) |
Li (2020) [19] |
EA (37) Sham EA (36) Control (31) |
EA 30.3 ± 4.2 Sham EA 30.5 ± 5.3 Control 30.8 ± 4.7 |
278.4 ± 7.3 277.1 ± 7.9 278.0 ± 7.6 |
EA on SP6, LI4 | Sham EA on SP6, LI4 | Control (epidural block) |
1. VAS Scores (positive a) 2. Serum β-EP levels (positive a) 3. Sufentanil/Ropivacaine usage (positive a) 4. Bleeding amount (positive a) 5. Oxytocin secretion period (NS) 6. Apgar score (NS) |
Ma (2011) [14] |
EA (92) Sham EA (94) Control (100) |
EA 26.15 ± 2.83 Sham EA 26.39 ± 2.96 Control 25.55 ± 3.00 |
38–41 wk | EA on SP6 | Sham EA on SP6 | Control (regular parturient in labor) |
1. VAS Scores 1-1. Needle retention (30 min) (positive a) 1-2. 2 h, 4 h after needle withdrawal (positive a) |
Mackenzie (2011) [20] |
EA (26) Manual (26) Sham manual & EA (27) Control (26) |
EA 31.0 ± 4.4 Manual 32.5 ± 5.1 Sham manual & EA 30.5 ± 5.1 Control 31.1 ± 5.1 |
37–41 wk | EA & manual on LI4, SP6, BL60, BL67 | Sham EA on LI4, SP6, BL60, BL67 | Control (standard care) |
1. Analgesia (epidural, parenteral) (NS ‡) 2. Clinical and neonatal outcome (NS ‡ ) |
Li (2019) [16] |
EA (37) Sham EA (36) Control (31) |
EA 30.4 ± 4.8 Sham EA 30.3 ± 5.2 Epidural block 30.4 ± 4.8 |
EA 278.5 ± 7.3 / Sham EA 277.1 ± 7.9 / Epidural block 278.0 ± 7.7 |
EA on SP6, LI4 | Sham EA on SP6, LI4 | - |
1. VAS Scores (positive a) 2. ACTH levels (positive a) 3. COR levels (positive a) 4. PCEA use (positive a) |
Qu (2007) [13] |
EA (18) Control (18) |
EA 28.7 ± 3.1 Control 28.9 ± 2.9 |
EA 39.6 ± 1.1 Control 39.9 ± 0.9 |
EA on LI4, SP6 | Control (Natural vaginal delivery without pain relief) | - |
1. VAS Score (positive a) 2. VAS (Relaxation) Score (positive a) 3. b-EP level (positive a) 4. 5-HT levels (positive a) |
Sun (2019) [17] |
EA (76) Control (76) |
EA 27.82 ± 3.14 Control 27.63 ± 3.62 |
EA 39.41 ± 0.34 Control 39.27 ± 0.31 |
EA on ear acupuncture (uterus, shen men point), SP6, LI4 | Control (standard obstetric care without acupuncture or EA) | - |
1. VAS Scores (positive a) 2. Labor duration (positive a) 3. Blood loss (positive a) 4. Delivery method (spontaneous) (positive a) 5. Fetal distress (positive a) 6. Apgar score (NS) |
Vixner (2014) [12] |
MA (83) EA (87) Control (83) |
MA 26.5 ± 4.8 EA 27.6 ± 4.6 SC 28.3 ± 5.0 |
MA 40 EA 39 SC 40 |
MA and EA Groups were treated with 13–21 needles, at 3 bilateral distal points and 4–8 bilateral local points, | EA | Control (Swedish clinical practice) |
1. Vas Score (NS) 2. Epidural analgesia use (positive§) |
Xiao (2019) [21] |
EA (60) Control (60) |
EA 27.62 ± 2.86 Control 27.72 ± 2.60 |
EA 274.55 ± 7.77 Control 275.60 ± 7.59 |
CSEA + PCEA + EA on LI4, PC6, ST36, SP6 | Control (CSEA + PCEA) | - |
1. VAS scores (positive a) 2. Complications 2-1. Fever, Urinary retention (positive c) 2-2. Skin itch, Rests (NS) 3. Use of oxytocin (positive c) 4. Instrumental delivery (NS) 5. Cesarean section (NS) 6. Duration and neonatal outcome 6-1. Duration (positive*) *Cer 3–10 cm positive c / second stage NS / Third stage positive a 6-2. Cord blood pH (NS) 6-3. Apgar score (NS) |
* 6 h positive bx.
† 12 h positive c.
‡ Manual + EA vs sham/control.
§ EA vs SC: odds ratio [OR] 0.35; [95% CI] 0.19–0.67.
ACTH = adrenocorticotropic hormone; β-EP = beta-endorphin; CSEA = combined spinal-epidural analgesia; CI = confidence interval; COR = cortisol; EA = electroacupuncture; IL-6 = interleukin 6; MA = manual acupuncture; NAPC = number of analgesic pump compressions; NS = not significant; OR = odds ratio; PCIA = patient-controlled intravenous analgesia; PCEA = patient-controlled epidural analgesia; PCT = procalcitonin; RCT = randomized controlled trial; VAS = visual analogue scale; 5-HT = serotonin.
Author (y) [ref] | Treatment (n) | Age (y) | Pregnancy period (wk) | Group 1 | Group 2 | Group 3 | Results |
---|---|---|---|---|---|---|---|
Dong (2015) [ |
EA1 (60) EA2 (60) Control (60) |
EA1 29.40 ± 2.96 EA2 29.12 ± 2.88 Control 28.98 ± 2.64 |
- | EA on EX-B2 | EA on SP6 | Control (routine intrapartum care) | (EA1 vs control / EA2 vs control) 1. VAS Scores (positive b, positive b) 2. Active labor phase duration (positive b, positive a) 3. Neonatal outcomes (NS) |
Jin (2023) [ |
EA1 (53 EA2 (53) Sham EA (52) |
EA1 30.83 ± 3.59 EA2 30.13 ± 3.31 Sham EA 31.19 ± 3.37 |
37.96 ± 1.64 38.32 ± 1.45 38.19 ± 1.28 |
PCIA (patient-controlled intravenous analgesia) + 2 Hz EA on ST36, SP6 | PCIA + 20/100 Hz EA on ST36, SP6 | PCIA + Sham EA | (EA1 vs sham EA / EA2 vs sham EA) 1. NAPC (number of analgesic pump compressions) at 6, 12, 24, 48 h (positive c, positive c) 2. VAS Scores at 6, 12, 24, 48 h (positive c, positive c) 3. Fentanyl consumption at 6, 12, 24, 48h (positive c, positive b 4. time to first exhaust (NS, NS) 5. Serum IL-6, PCT at 12, 48 h (NS between three groups) |
Li (2020) [ |
EA (37) Sham EA (36) Control (31) |
EA 30.3 ± 4.2 Sham EA 30.5 ± 5.3 Control 30.8 ± 4.7 |
278.4 ± 7.3 277.1 ± 7.9 278.0 ± 7.6 |
EA on SP6, LI4 | Sham EA on SP6, LI4 | Control (epidural block) | 1. VAS Scores (positive a) 2. Serum β-EP levels (positive a) 3. Sufentanil/Ropivacaine usage (positive a) 4. Bleeding amount (positive a) 5. Oxytocin secretion period (NS) 6. Apgar score (NS) |
Ma (2011) [ |
EA (92) Sham EA (94) Control (100) |
EA 26.15 ± 2.83 Sham EA 26.39 ± 2.96 Control 25.55 ± 3.00 |
38–41 wk | EA on SP6 | Sham EA on SP6 | Control (regular parturient in labor) | 1. VAS Scores 1-1. Needle retention (30 min) (positive a) 1-2. 2 h, 4 h after needle withdrawal (positive a) |
Mackenzie (2011) [ |
EA (26) Manual (26) Sham manual & EA (27) Control (26) |
EA 31.0 ± 4.4 Manual 32.5 ± 5.1 Sham manual & EA 30.5 ± 5.1 Control 31.1 ± 5.1 |
37–41 wk | EA & manual on LI4, SP6, BL60, BL67 | Sham EA on LI4, SP6, BL60, BL67 | Control (standard care) | 1. Analgesia (epidural, parenteral) (NS 2. Clinical and neonatal outcome (NS |
Li (2019) [ |
EA (37) Sham EA (36) Control (31) |
EA 30.4 ± 4.8 Sham EA 30.3 ± 5.2 Epidural block 30.4 ± 4.8 |
EA 278.5 ± 7.3 / Sham EA 277.1 ± 7.9 / Epidural block 278.0 ± 7.7 |
EA on SP6, LI4 | Sham EA on SP6, LI4 | - | 1. VAS Scores (positive a) 2. ACTH levels (positive a) 3. COR levels (positive a) 4. PCEA use (positive a) |
Qu (2007) [ |
EA (18) Control (18) |
EA 28.7 ± 3.1 Control 28.9 ± 2.9 |
EA 39.6 ± 1.1 Control 39.9 ± 0.9 |
EA on LI4, SP6 | Control (Natural vaginal delivery without pain relief) | - | 1. VAS Score (positive a) 2. VAS (Relaxation) Score (positive a) 3. b-EP level (positive a) 4. 5-HT levels (positive a) |
Sun (2019) [ |
EA (76) Control (76) |
EA 27.82 ± 3.14 Control 27.63 ± 3.62 |
EA 39.41 ± 0.34 Control 39.27 ± 0.31 |
EA on ear acupuncture (uterus, shen men point), SP6, LI4 | Control (standard obstetric care without acupuncture or EA) | - | 1. VAS Scores (positive a) 2. Labor duration (positive a) 3. Blood loss (positive a) 4. Delivery method (spontaneous) (positive a) 5. Fetal distress (positive a) 6. Apgar score (NS) |
Vixner (2014) [ |
MA (83) EA (87) Control (83) |
MA 26.5 ± 4.8 EA 27.6 ± 4.6 SC 28.3 ± 5.0 |
MA 40 EA 39 SC 40 |
MA and EA Groups were treated with 13–21 needles, at 3 bilateral distal points and 4–8 bilateral local points, | EA | Control (Swedish clinical practice) | 1. Vas Score (NS) 2. Epidural analgesia use (positive |
Xiao (2019) [ |
EA (60) Control (60) |
EA 27.62 ± 2.86 Control 27.72 ± 2.60 |
EA 274.55 ± 7.77 Control 275.60 ± 7.59 |
CSEA + PCEA + EA on LI4, PC6, ST36, SP6 | Control (CSEA + PCEA) | - | 1. VAS scores (positive a) 2. Complications 2-1. Fever, Urinary retention (positive c) 2-2. Skin itch, Rests (NS) 3. Use of oxytocin (positive c) 4. Instrumental delivery (NS) 5. Cesarean section (NS) 6. Duration and neonatal outcome 6-1. Duration (positive 6-2. Cord blood pH (NS) 6-3. Apgar score (NS) |
6 h positive bx. 12 h positive c. Manual + EA vs sham/control. EA vs SC: odds ratio [OR] 0.35; [95% CI] 0.19–0.67. ACTH = adrenocorticotropic hormone; β-EP = beta-endorphin; CSEA = combined spinal-epidural analgesia; CI = confidence interval; COR = cortisol; EA = electroacupuncture; IL-6 = interleukin 6; MA = manual acupuncture; NAPC = number of analgesic pump compressions; NS = not significant; OR = odds ratio; PCIA = patient-controlled intravenous analgesia; PCEA = patient-controlled epidural analgesia; PCT = procalcitonin; RCT = randomized controlled trial; VAS = visual analogue scale; 5-HT = serotonin.